| Browse |
| Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants. |
| Lineage (WHO label)   | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |
|---|---|---|---|---|---|---|---|---|---|---|
| B.1.1.403 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| B.1.636 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| B.1.126 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| BQ.1.1.47 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XDQ.3 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| JD.1.1.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBC.1.1 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| FY.9 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.1.31.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| GK.1.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.1.5.27 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.9 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| CK.1.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| CM.8.1.3 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| CA.3.1 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| BA.5.2.61 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.2.5 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| ED.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| BU.2 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.1.6 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| BN.1.3.11 | S | WuhanCoV-spk1 | TGTGGTTCATAAAAATTCCTTTGTG | 25 | 32 | 24900 | 24876 | R | -23857.7 | Japan |
| XBB.9 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| CK.1.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| CM.8.1.3 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| CA.3.1 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BA.5.2.61 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| XBB.2.5 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| ED.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BU.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| XBB.1.6 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BN.1.3.11 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -17890.7 | US |
| XCG | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| B.28 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| B.1.1.77 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| JN.1.2.1 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| HK.13.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| HV.1.9 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| XBB.2.3.16 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BM.2.1 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| XBE | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BE.1.4.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BA.2.3.12 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BA.2.3.14 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| CP.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BQ.1.1.39 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BF.40 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BN.1.3.3 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BM.2 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| BQ.1.1.57 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| EF.1.3 | N | US-CDC-N-2 | TTACAAACATTGGCCGCAAA | 20 | 40 | 29164 | 29183 | F | -21115.5 | US |
| Lineage (WHO label) | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |